NCT00146666Unknown2 期
Evaluation of FM220 in Patients With Peripheral Arterial Disease (PAD)
FlowMedic4 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2005年9月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 发起方
- 入组人数
- 90
- 试验地点
- 4
- 主要终点
- Increase in Peak Walking Time as determined on graded treadmill test at 12 weeks
研究概览
简要总结
The purpose of this study is to determine whether 12 weeks of daily home use of the FM220 in the most affected leg of patients with PAD and claudication, will improve peak walking time (PWT) at three months as compared with a non-treated control group.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 40 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients aged 40 or more.
- •Peripheral arterial disease as determined by resting ABI<0.
- •Reduction in post exercise Ankle Brachial Index (ABI) of > 20% in the symptomatic limb.
- •Stable claudication for the past three months
- •Baseline PWT between 1 and 10 minutes
- •If the patient is under claudication drug therapy (eg. cilostazol and pentoxifvlline) the use and dose of these drugs has been stable for the last 60 days.
- •If the patient is receiving of statin and antiplatelet therapy, the use and dose of these drugs has been stable for the last 60 days.
排除标准
- •Any active pathological heart, muscular, neurological, orthopedic, cognitive or pulmonary disease which might interfere with patient compliance or ability to walk on a treadmill in the opinion of the investigator.
- •Non compressible arteries as defined by ABI>1.1
- •Clinical evidence of acute or subacute superficial or deep venous thrombosis confirmed by continuous-wave Doppler in the affected extremity.
- •Deep venous insufficiency on clinical grounds or by lab measurements.
- •Prior below-knee surgical revascularization procedure within the last 6 months.
- •Significant likelihood of lower extremity arterial revascularization procedure within the next 6 months.
- •Ulcer, cellulitis, skin conditions, or superficial thrombophlebitis in regions covered by the compression device preventing use of the device.
- •Acute pulmonary embolism.
- •Osteomyelitis of the lower extremity.
- •Gangrene of the lower extremity.
- •Acute limb ischemia.
- •Clinical scenarios in which increased venous or lymphatic return is undesirable.
- •Painful calf conditions which would exclude use of the pump.
- •Peripheral neuropathy that, in the opinion of the investigator, would prevent patient from accurately assessing claudication symptoms or identifying Cutaneous comfort of the device Vein ligation.
- •Pulmonary edema.
- •Significant aorto-iliac disease as demonstrated by physical examination or objective testing. Absence of aorto-iliac disease must be documented by segmental testing performed within 90 days of study enrollment.
- •Critical leg ischemia with evidence of rest pain, ischemic ulceration, gangrene.
- •Participation in any clinical trial within the past 30 days.
- •Morbid obesity, defined by BMI>40, weight greater than 300 lbs or leg circumference greater than 19.7 inches.
结局指标
主要结局
Increase in Peak Walking Time as determined on graded treadmill test at 12 weeks
次要结局
未报告次要终点
研究者
研究点 (4)
Loading locations...
相似试验
招募中
3 期
Randomized Controlled Trial in Patients on Long-term Colchicine With Colchicine-resistant Familial Mediterranean Fever (FMF) to Evaluate the Efficacy of On-demand Anakinra Treatment for Painful Attacks in Patients Who Refuse Continuous Daily TherapyFMFNCT06336733Assistance Publique - Hôpitaux de Paris50
终止
2 期
A Study To Evaluate The Safety And Efficacy Of PF-04958242 In Subjects With Cognitive Impairment Associated With Schizophrenia (CIAS)Cognitive Impairment Associated With Schizophrenia (CIAS)NCT02855411Biogen35
终止
2 期
Pilot Efficacy and Safety Study of Oral DF2156A in Patients With Active Bullous PemphigoidBullous PemphigoidNCT01571895Dompé Farmaceutici S.p.A4
终止
2 期
An Evaluation Of PF-03715455 In Moderate To Severe Chronic Obstructive Pulmonary DiseasePulmonary Disease, Chronic ObstructiveNCT02366637Pfizer13
已完成
不适用
Assessing the Clinical Performance of Two Frequent Replacement Silicone Hydrogel Multifocal Contact LensesPresbyopiaNCT05702541Alcon Research16